HEALTHSTREAM INC(HSTM)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,100 of 2,879 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
HSTM Stock Analysis & AI Quality Score
AI stock analysis and institutional research for HEALTHSTREAM INC (HSTM), a Technology sector company. 13F Pro's AI-powered ranking engine scores HSTM at 56.4/100 on a 32-signal composite quality model, placing it at rank #1,100 of 2,879 stocks — the top half of the AI-ranked universe. HSTM scores in the top quartile across free cash flow (81.5). Areas of concern include revenue scale (29.9), which score below median versus the broader universe. Shareholder dilution risk is elevated at 36.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), HEALTHSTREAM INC reports quarterly revenue of $81.2M, net income of $5.9M, an operating margin of 9.3%. Top institutional holders of HSTM by reported 13-F value include BlackRock,, DIMENSIONAL FUND ADVISORS, Copeland Capital Management,, based on the most recent SEC filings. HSTM trades on the Nasdaq exchange and files with the SEC under CIK 1095565. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HSTM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HEALTHSTREAM INC directly from SEC EDGAR. HEALTHSTREAM INC's 13F Pro composite quality score has ranged between 8 and 61 since 2021, currently 56.4 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q1 2026
$81.2M
Net Income
Q1 2026
$5.9M
Free Cash Flow
Q1 2026
$26.4M
Operating Margin
Q1 2026
9.3%
ROIC
Q1 2026
2.1%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+9.0% YoYNet Income
+20.6% YoYOperating Income
+26.3% YoYEPS (Diluted)
+22.0% YoYTotal Assets
+4.1% YoYOp. Cash Flow
-1.0% YoY| Metric | FY 2025 | FY 2023 | FY 2022 | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|---|---|---|
| Revenue | $304.1M +9.0% | $279.1M +4.6% | $266.8M +9.0% | $244.8M -3.7% | $254.1M +2.6% | $247.7M |
| Net Income | $18.3M +20.6% | $15.2M +25.8% | $12.1M -14.2% | $14.1M -10.6% | $15.8M +57.6% | $10.0M |
| Operating Income | $20.2M +26.3% | $16.0M +28.7% | $12.4M -21.3% | $15.8M +7.5% | $14.7M +56.5% | $9.4M |
| EPS (Diluted) | $0.61 +22.0% | $0.50 +28.2% | $0.39 -11.4% | $0.44 -10.2% | $0.49 +58.1% | $0.31 |
| Total Assets | $520.4M +4.1% | $499.9M +0.4% | $497.7M -0.5% | $500.3M +2.2% | $489.5M +19.1% | $411.1M |
| Operating Cash Flow | $63.3M -1.0% | $64.0M +25.0% | $51.2M +42.7% | $35.9M -45.4% | $65.7M +40.6% | $46.7M |
AI Insight: HSTM Financial Trends
HSTM revenue accelerated to $81M in Q1 2026 — highest in the dataset — while operating income rebounded sharply to $8M after a Q4 2025 dip.
• Revenue grew steadily from $72M in Q2 2024 to $81M in Q1 2026, a 12.5% increase over seven quarters.
• Operating income nearly doubled from $4M in Q2 2024 to $8M in Q1 2026, suggesting gradual margin expansion.
• Operating cash flow surged to $27M in Q1 2026, matching the Q1 2025 peak and well above Q2 2025's trough of $5M.
• Equity declined modestly from $363M in Q1 2025 to $352M in Q1 2026, a mild balance-sheet contraction.
⚠ Q4 2025 operating income collapsed to $2M — the lowest in the dataset — despite $80M revenue; cost pressures warrant scrutiny.
⚠ Operating cash flow is highly seasonal and volatile, swinging from $5M to $27M; sustainability of Q1 2026 levels is unclear.
⚠ Total debt data is absent across all periods, limiting full leverage and capital-structure assessment.
AI Insight: HSTM Ratio Trends
Q1 2026 operating margin rebounds sharply to 9.2% after Q4 2025's anomalous 3.0% trough, but TTM margin of 7.5% signals the Q4 dip is still dragging full-year profitability.
• Operating margin recovered strongly from 3.0% in Q4 2025 to 9.2% in Q1 2026, the highest single-quarter reading in the dataset.
• ROIC improved from 2.7% in Q4 2025 to 8.5% in Q1 2026, nearly matching Q3 2025's peak of 8.7%.
• Q4 2025 saw a broad-based collapse across all metrics — OpMargin 3.0%, ROE 2.9%, ROIC 2.7% — well below any other quarter shown.
• TTM NPM of 6.4% and ROA of 3.8% sit in the middle of the observed range, reflecting Q4 2025's drag on trailing figures.
⚠ Q4 2025's sharp margin collapse to 3.0% OpMargin remains unexplained — recurrence would materially impair full-year profitability.
⚠ TTM ROIC of 6.6% lags the Q1 2026 quarterly annualized rate of 8.5% — sustained Q4-style weakness could reverse the improving trend.
⚠ D/E data is entirely absent; leverage picture is unclear, limiting balance-sheet risk assessment.
Get alerted when HSTM's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for HEALTHSTREAM INC including:
Top Institutional Holders of HSTM
BlackRock, Inc.
$79.8M3,851,929 shDIMENSIONAL FUND ADVISORS LP
$30.2M1,456,043 shCopeland Capital Management, LLC
$26.4M1,276,739 shVANGUARD CAPITAL MANAGEMENT LLC
$21.7M1,047,927 shSTATE STREET CORP
$20.6M995,557 shVANGUARD PORTFOLIO MANAGEMENT LLC
$19.1M921,846 shTWO SIGMA INVESTMENTS, LP
$17.5M844,420 shGEODE CAPITAL MANAGEMENT, LLC
$14.8M714,747 shRENAISSANCE TECHNOLOGIES LLC
$9.9M477,848 shFirst Eagle Investment Management, LLC
$8.8M425,698 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $79.8M | 3,851,929 |
| DIMENSIONAL FUND ADVISORS LP | $30.2M | 1,456,043 |
| Copeland Capital Management, LLC | $26.4M | 1,276,739 |
| VANGUARD CAPITAL MANAGEMENT LLC | $21.7M | 1,047,927 |
| STATE STREET CORP | $20.6M | 995,557 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $19.1M | 921,846 |
| TWO SIGMA INVESTMENTS, LP | $17.5M | 844,420 |
| GEODE CAPITAL MANAGEMENT, LLC | $14.8M | 714,747 |
| RENAISSANCE TECHNOLOGIES LLC | $9.9M | 477,848 |
| First Eagle Investment Management, LLC | $8.8M | 425,698 |
More Technology Companies
View all Technology →Put HSTM on your watchlist
Track score changes the day HEALTHSTREAM INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is HSTM a good stock to buy?
13F Pro's AI-powered analysis of HEALTHSTREAM INC (HSTM) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HSTM are available on the HSTM stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own HSTM?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HSTM. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HEALTHSTREAM INC's investment landscape.